封面
市場調查報告書
商品編碼
1595264

經皮腎結石清除市場:按成分、類型和最終用戶分類 - 全球預測 2025-2030

Percutaneous Nephrolithotomy Market by Component (Accessories, Devices, Services), Type (Micro-Percutaneous Nephrolithotomy, Mini Percutaneous Nephrolithotomy, Ultra-Mini Percutaneous Nephrolithotomy), End-Users - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年經皮腎結石清除市值為183.5億美元,預計2024年將達到196.6億美元,複合年成長率為7.90%,2030年將達到312億美元,預計將達到5000萬美元。

經皮鏡取石術 (PCNL) 是一種微創外科手術,旨在清除對於其他治療(例如體外震波碎石術或輸尿管鏡檢查)來說太大的腎結石。穿過您背部的皮膚切開一個小切口,然後將結石直接從腎臟中取出。當較大或複雜的腎結石導致反覆性行為感染、劇烈疼痛或尿路阻塞時,主要需要進行 PCNL。 PCNL主要在傳統方法失效時應用,已成為泌尿系統診所、醫院和專科診所的重要組成部分。最終用途範圍包括許多擁有熟練醫生和先進影像處理工具的醫療機構。根據市場洞察,由於生活方式因素和飲食習慣,全球腎結石盛行率不斷上升,加上醫療保健支出不斷增加,正在顯著推動 PCNL 需求。手術設備的技術進步和術後效果的改善進一步推動了市場的成長。潛在的商機存在於新興市場,這些市場的醫療保健系統預計將擴大,而對人工智慧和機器人技術的投資以提高手術精度可能會帶來變革。然而,市場成長面臨手術成本高、需要專門訓練以及術後出血和感染等併發症等挑戰。需要創新的領域包括開發更具成本效益的手術器械、增強成像技術以及簡化培訓模組以擴大手術機會。預防結石復發的研究可以提供顯著的業務成長前景。隨著市場競爭的持續,以及改善患者治療效果和成本效率的趨勢,對技術和患者照護的混合關注可以產生顯著的效益。因此,相關人員應將其策略與創新技術和培訓基礎設施結合起來,以最大限度地擴大 PCNL 不斷擴大的潛在市場影響。

主要市場統計
基準年[2023] 183.5億美元
預計年份 [2024] 196.6億美元
預測年份 [2030] 312.5億美元
複合年成長率(%) 7.90%

市場動態:快速發展的經皮皮腎結石去除市場的關鍵市場洞察

供需的動態交互作用正在改變經經皮腎結石清除市場。透過了解這些不斷變化的市場動態,公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險,並了解消費行為及其對製造成本的影響,並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 全球腎結石數量增加
    • 傾向早期診斷和治療醫療狀況
    • 人們越來越偏好微創醫療程序
  • 市場限制因素
    • 經皮腎結石清除裝置的技術問題和高成本
  • 市場機會
    • 經經皮腎結石清除的創新與進步
    • 超小型經皮皮腎結石取出術的持續研究
  • 市場挑戰
    • 經經皮腎結石清除相關的併發症和風險

波特五經皮腎結石去除市場

波特的五力框架是了解經皮腎結石清除市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢,解決弱點並避免潛在的挑戰,從而確保更強大的市場地位。

PESTLE分析:了解對經皮皮腎結石去除市場的外部影響

外部宏觀環境因素在塑造經皮皮腎結石清除市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素,公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化,並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解經經皮腎結石清除市場的競爭格局

經皮腎結石清除市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢,為供應商提供了製定策略決策所需的洞察力,使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣經皮皮腎結石清除市場供應商的績效評估

FPNV 定位矩陣是評估經經皮腎結石清除市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商,從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商,並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了經經皮腎結石去除市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說,對經皮皮腎結石清除市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標,公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰,利用新的商機,並取得長期成功。

本報告對市場進行了全面分析,涵蓋關鍵重點領域:

1. 市場滲透率:詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓:辨識新興市場的成長機會,評估現有領域的擴張潛力,並提供未來成長的策略藍圖。

3. 市場多元化:分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報:徹底分析競爭格局,檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新:重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題,以幫助相關人員做出明智的決策:

1.目前的市場規模和未來的成長預測是多少?

2. 哪些產品、區隔市場和地區提供最佳投資機會?

3.塑造市場的主要技術趨勢和監管影響是什麼?

4.主要廠商的市場佔有率和競爭地位如何?

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼?

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球腎結石發生率增加
      • 疾病早期診斷和治療的趨勢
      • 對微創醫療程序的偏好增加
    • 抑制因素
      • 經皮腎結石清除裝置的技術問題和高成本
    • 機會
      • 經經皮腎結石清除的創新與進步
      • 超小型經皮鏡取石術的研究正在進行中
    • 任務
      • 經經皮腎結石清除相關的併發症和風險
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章經皮皮腎結石清除市場:依組成部分

  • 配件
  • 裝置
  • 服務

第7章經皮皮腎結石清除市場:依類型

  • 經皮取石術
  • 微型經皮皮腎結石取出術
  • 超微型經皮皮腎結石清除術

第8章經皮皮腎結石清除市場:依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第9章北美和南美經皮皮腎結石清除市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太經經皮腎結石清除市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東、非洲經皮腎結石清除市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣,2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Advin Urology
  • Allengers Medical Systems Ltd.
  • Attikouris Enterprises Ltd.
  • Boston Scientific Corporation
  • Coloplast Corporation
  • Cook Group Incorporated
  • Dornier MedTech
  • EMS Electro Medical Systems SA
  • EDAP TMS SA
  • ELMED Inc.
  • Envaste Limited
  • Karl Storz Se & Co. KG
  • Medical Device Business Services, Inc.
  • Medispec Ltd.
  • Olympus Corporation
  • Richard Wolf GmbH
  • Rocamed
  • Siemens AG
  • Stryker Corporation
Product Code: MRR-C002B1C99560

The Percutaneous Nephrolithotomy Market was valued at USD 18.35 billion in 2023, expected to reach USD 19.66 billion in 2024, and is projected to grow at a CAGR of 7.90%, to USD 31.25 billion by 2030.

Percutaneous Nephrolithotomy (PCNL) is a minimally invasive surgical procedure designed to remove kidney stones that are too large for other treatments like extracorporeal shock wave lithotripsy or ureteroscopy. It involves creating a small incision in the back through the skin to reach and extract the stone directly from the kidney. The necessity for PCNL arises primarily when large or complicated kidney stones cause recurrent infections, significant pain, or obstruction in the urinary tract. It is primarily applied in procedures where traditional methods fail, making it vital in urology practices, hospitals, and specialized clinics. The end-use scope prominently includes healthcare facilities with skilled practitioners and advanced imaging tools. Market insights reveal that a growing global prevalence of kidney stones, attributed to lifestyle factors and dietary habits, alongside increasing healthcare expenditures, is significantly driving PCNL demand. Technological advancements in surgical devices and improved postoperative outcomes further buoy market growth. Potential opportunities lie in emerging markets with healthcare systems poised for expansion, and investments in artificial intelligence and robotics to enhance surgical precision can be transformative. However, market growth faces challenges like the high cost of the procedure, the requirement for specialized training, and postoperative complications like bleeding or infection. Areas ripe for innovation include the development of more cost-effective surgical tools, enhanced imaging technologies, and simplified training modules to broaden procedure accessibility. Research into preventing stone recurrence could offer significant business growth prospects. The market remains competitive, with a growing emphasis on improving patient outcomes and cost-efficiency, suggesting a hybrid focus on technology and patient care can yield substantial returns. Thus, stakeholders should align their strategies to innovative technologies and training infrastructure to maximize the potential of PCNL's expanding market presence.

KEY MARKET STATISTICS
Base Year [2023] USD 18.35 billion
Estimated Year [2024] USD 19.66 billion
Forecast Year [2030] USD 31.25 billion
CAGR (%) 7.90%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Percutaneous Nephrolithotomy Market

The Percutaneous Nephrolithotomy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidences of kidney stones among individuals worldwide
    • Inclination towards early diagnosis and treatment of medical conditions
    • Growing preference towards minimally invasive medical procedures
  • Market Restraints
    • Technical issues and high cost of percutaneous nephrolithotomy equipment
  • Market Opportunities
    • Innovations and advancements in percutaneous nephrolithotomy
    • Ongoing research on ultra-mini-percutaneous nephrolithotomy
  • Market Challenges
    • Complications and risks associated with percutaneous nephrolithotomy

Porter's Five Forces: A Strategic Tool for Navigating the Percutaneous Nephrolithotomy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Percutaneous Nephrolithotomy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Percutaneous Nephrolithotomy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Percutaneous Nephrolithotomy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Percutaneous Nephrolithotomy Market

A detailed market share analysis in the Percutaneous Nephrolithotomy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Percutaneous Nephrolithotomy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Percutaneous Nephrolithotomy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Percutaneous Nephrolithotomy Market

A strategic analysis of the Percutaneous Nephrolithotomy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Percutaneous Nephrolithotomy Market, highlighting leading vendors and their innovative profiles. These include Advin Urology, Allengers Medical Systems Ltd., Attikouris Enterprises Ltd., Boston Scientific Corporation, Coloplast Corporation, Cook Group Incorporated, Dornier MedTech, E.M.S. Electro Medical Systems S.A., EDAP TMS SA, ELMED Inc., Envaste Limited, Karl Storz Se & Co. KG, Medical Device Business Services, Inc., Medispec Ltd., Olympus Corporation, Richard Wolf GmbH, Rocamed, Siemens AG, and Stryker Corporation.

Market Segmentation & Coverage

This research report categorizes the Percutaneous Nephrolithotomy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Component, market is studied across Accessories, Devices, and Services.
  • Based on Type, market is studied across Micro-Percutaneous Nephrolithotomy, Mini Percutaneous Nephrolithotomy, and Ultra-Mini Percutaneous Nephrolithotomy.
  • Based on End-Users, market is studied across Ambulatory Surgical Centers, Clinics, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of kidney stones among individuals worldwide
      • 5.1.1.2. Inclination towards early diagnosis and treatment of medical conditions
      • 5.1.1.3. Growing preference towards minimally invasive medical procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Technical issues and high cost of percutaneous nephrolithotomy equipment
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovations and advancements in percutaneous nephrolithotomy
      • 5.1.3.2. Ongoing research on ultra-mini-percutaneous nephrolithotomy
    • 5.1.4. Challenges
      • 5.1.4.1. Complications and risks associated with percutaneous nephrolithotomy
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Percutaneous Nephrolithotomy Market, by Component

  • 6.1. Introduction
  • 6.2. Accessories
  • 6.3. Devices
  • 6.4. Services

7. Percutaneous Nephrolithotomy Market, by Type

  • 7.1. Introduction
  • 7.2. Micro-Percutaneous Nephrolithotomy
  • 7.3. Mini Percutaneous Nephrolithotomy
  • 7.4. Ultra-Mini Percutaneous Nephrolithotomy

8. Percutaneous Nephrolithotomy Market, by End-Users

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Clinics
  • 8.4. Hospitals

9. Americas Percutaneous Nephrolithotomy Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Percutaneous Nephrolithotomy Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Percutaneous Nephrolithotomy Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advin Urology
  • 2. Allengers Medical Systems Ltd.
  • 3. Attikouris Enterprises Ltd.
  • 4. Boston Scientific Corporation
  • 5. Coloplast Corporation
  • 6. Cook Group Incorporated
  • 7. Dornier MedTech
  • 8. E.M.S. Electro Medical Systems S.A.
  • 9. EDAP TMS SA
  • 10. ELMED Inc.
  • 11. Envaste Limited
  • 12. Karl Storz Se & Co. KG
  • 13. Medical Device Business Services, Inc.
  • 14. Medispec Ltd.
  • 15. Olympus Corporation
  • 16. Richard Wolf GmbH
  • 17. Rocamed
  • 18. Siemens AG
  • 19. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. PERCUTANEOUS NEPHROLITHOTOMY MARKET RESEARCH PROCESS
  • FIGURE 2. PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PERCUTANEOUS NEPHROLITHOTOMY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PERCUTANEOUS NEPHROLITHOTOMY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PERCUTANEOUS NEPHROLITHOTOMY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PERCUTANEOUS NEPHROLITHOTOMY MARKET DYNAMICS
  • TABLE 7. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MICRO-PERCUTANEOUS NEPHROLITHOTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MINI PERCUTANEOUS NEPHROLITHOTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRA-MINI PERCUTANEOUS NEPHROLITHOTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 146. PERCUTANEOUS NEPHROLITHOTOMY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. PERCUTANEOUS NEPHROLITHOTOMY MARKET, FPNV POSITIONING MATRIX, 2023